Allergic bronchopulmonary aspergillosis
- PMID: 31690385
- DOI: 10.2500/aap.2019.40.4262
Allergic bronchopulmonary aspergillosis
Abstract
Allergic bronchopulmonary aspergillosis (ABPA) occurs in patients with asthma or cystic fibrosis, and results in pulmonary infiltrates, tenacious mucus plugs that harbor hyphae of Aspergillus fumigatus, elevations of total serum immunoglobulin E concentration and peripheral blood and sputum eosinophilia. Bronchiectasis is an irreversible complication of ABPA. The key to early diagnosis is to consider ABPA in anyone with asthma or cystic fibrosis and with a positive skin test result for Aspergillus, and/or recurrent infiltrates on radiographs. The differential diagnosis for ABPA in patients with asthma includes diseases in which there is an overlap of asthma, peripheral blood eosinophilia, and radiographic infiltrates. Examples include chronic eosinophilic pneumonia, Churg-Strauss syndrome, drug-induced pulmonary infiltrates, infection with a parasite, asthma with atelectasis, and lymphoma. Mucus plugging that causes a "tree in bud" pattern on computerized tomography examination of the lungs may be from ABPA or other conditions, such as nontuberculous (atypical) mycobacteria (Mycobacteria avium-Mycobacteria intracellulare complex). Prednisone is indicated to clear pulmonary infiltrates, and a usual course is for 3 months. Itraconazole and voriconazole are adjunctive, and drug-drug interactions must be considered because azoles decrease elimination of various medications. Although not familial in most patients, presentation of Aspergillus fumigatus f1 (Asp f1) antigen is restricted to specific major histocompatibility complex (MHC) class II molecules, Human Leukocyte Antigen-DR2 (HLA-DR2), and HLA-DR5. There is an increased number of CD4+ T-helper type 2 lymphocytes in bronchoalveolar lavage, and A. fumigatus can serve as a growth factor of eosinophils potentiating the effects of interleukin (IL) 3, IL-5, and Granulocyte-colony stimulating factor (G-CSF). Eosinophils interact directly with A. fumigatus spores and generate extracellular traps, which can injure the bronchial epithelium.
Similar articles
-
Chapter 18: Allergic bronchopulmonary aspergillosis.Allergy Asthma Proc. 2012 May-Jun;33 Suppl 1:61-63. doi: 10.2500/aap.2012.33.3551. Allergy Asthma Proc. 2012. PMID: 22794691 Review.
-
Allergic bronchopulmonary aspergillosis in a patient with cystic fibrosis: diagnostic criteria when the IgE level is less than 500 IU/mL.Ann Allergy Asthma Immunol. 2005 Nov;95(5):488-93. doi: 10.1016/S1081-1206(10)61177-5. Ann Allergy Asthma Immunol. 2005. PMID: 16312174
-
Allergic bronchopulmonary aspergillosis.J Allergy Clin Immunol. 2002 Nov;110(5):685-92. doi: 10.1067/mai.2002.130179. J Allergy Clin Immunol. 2002. PMID: 12417875 Review.
-
Pathophysiology and immunology of allergic bronchopulmonary aspergillosis.Med Mycol. 2005 May;43 Suppl 1:S203-6. doi: 10.1080/13693780500052255. Med Mycol. 2005. PMID: 16110813 Review.
-
Induced sputum eosinophils and neutrophils and bronchiectasis severity in allergic bronchopulmonary aspergillosis.Eur Respir J. 2000 Dec;16(6):1095-101. doi: 10.1034/j.1399-3003.2000.16f13.x. Eur Respir J. 2000. PMID: 11292112
Cited by
-
Active herpesviruses are associated with intensive care unit (ICU) admission in patients pulmonary infection and alter the respiratory microbiome.Front Microbiol. 2024 Aug 9;15:1441476. doi: 10.3389/fmicb.2024.1441476. eCollection 2024. Front Microbiol. 2024. PMID: 39184027 Free PMC article.
-
Eosinophils as drivers of bacterial immunomodulation and persistence.Infect Immun. 2024 Sep 10;92(9):e0017524. doi: 10.1128/iai.00175-24. Epub 2024 Jul 15. Infect Immun. 2024. PMID: 39007622 Free PMC article. Review.
-
Coexistence of Eosinophilic Granulomatosis With Polyangiitis and Allergic Bronchopulmonary Aspergillosis: A Fascinating Relationship.Cureus. 2024 Apr 9;16(4):e57917. doi: 10.7759/cureus.57917. eCollection 2024 Apr. Cureus. 2024. PMID: 38601813 Free PMC article.
-
Development of a mobile app for the evaluation of patients with chronic rhinosinusitis.Braz J Otorhinolaryngol. 2024 Mar-Apr;90(2):101375. doi: 10.1016/j.bjorl.2023.101375. Epub 2023 Dec 14. Braz J Otorhinolaryngol. 2024. PMID: 38237485 Free PMC article.
-
Serum Cytokine Biomarkers for Use in Diagnosing Pulmonary Tuberculosis versus Chronic Pulmonary Aspergillosis.Infect Drug Resist. 2023 Apr 14;16:2217-2226. doi: 10.2147/IDR.S403401. eCollection 2023. Infect Drug Resist. 2023. PMID: 37081946 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
